Institutional members access full text with Ovid®

Share this article on:

Augmentation of Wound Healing Using Monochromatic Infrared Energy: Exploration of a New Technology for Wound Management

Horwitz Lon R. DPM CWS; Burke, Thomas J. PhD; Carnegie, Dale DPM
Advances in Skin & Wound Care: January-February 1999
SHORT REPORT: PDF Only

Abstract

The results presented in this paper document healing of different types of extremity wounds with 890 nanometer (nm) monochromatic infrared energy. Recalcitrant dermal lesions, including venous ulcers, diabetic ulcers, and a wound related to scleroderma, were treated with a Food and Drug Administration-cleared infrared device. The infrared protocol was instituted after conventional management protocols were shown to be ineffective. The rate and quality of healing of these previously refractory wounds, following use of monochromatic infrared energy, may be related to local increases in nitric oxide concentration. Increases in nitric oxide previously have been demonstrated to correlate with vasodilatory and anabolic responses. Further research is needed to confirm the results found in these patients.

ADV WOUND CARE 1999;12:35-40

Lon R. Horwitz, DPM, CWS, is on the teaching faculty and attending staff, Department of Surgery, Podiatric Section, at the Denver Veterans Affairs Medical Center, Denver, CO. Thomas J. Burke, PhD, is Associate Professor of Medicine, Department of Medicine, at the University of Colorado Medical School, Denver, CO, and President, Integrated Systems Physiology, Aurora, CO. Dale Carnegie, DPM, is a staff podiatrist in the Department of Orthopaedics, Podiatry Section, at Denver Health Medical Center, Denver, CO. The monochromatic infrared light used in this study was supplied by Anodyne Therapeutics, Denver, CO. Submitted August 28, 1998; accepted in revised form October 21, 1998.

© 1999 Lippincott Williams & Wilkins, Inc.